DNSP-11buy The DNSP-11 peptide represents a significant development in neuroprotection, particularly for dopamine neurons. This 11-mer peptide, derived from the pro-domain of the human Glial Cell Line-Derived Neurotrophic Factor (GDNF) family, has demonstrated potent neurotrophic and neuroprotective activities.DNSP-11 Peptide ≥98% (HPLC), powder Early research suggests that DNSP-11 is the first peptide from this specific region of GDNF to exhibit in vivo trophic-like actions, positioning it as a promising candidate for therapeutic interventions aimed at neurodegenerative conditions affecting dopaminergic systems.作者：MJ Stenslik—These results demonstrate thatDNSP-11 can be delivered to the CNS intranasally, and maintains its neuroactive properties on the nigrostriatal system in a rat ... Its ability to support the survival of fetal mesencephalic neurons and protect human dopaminergic neuroblastoma cells against induced cell death highlights its potential to safeguard critical neural pathwaysIn the MN9D dopaminergic neuronal cell line, DNSP-11provides protection against staurosporine and 6-hydroxydopamine-induced cell death, significantly ....
DNSP-11 is an 11 amino acid peptide that originates from the pro-GDNF domain. Specifically, it is a predicted endopeptidase cleavage product from the proregion of human pre-proGDNF2024年7月26日—DNSP-11 peptideis a lab-made research compound derived from the proprotein portion of GDNF. It comprises eleven (11) amino acid sequences, .... This synthetic, amidated peptide is characterized by its precise sequence, comprising eleven consecutive amino acid residues. Its derivation from a naturally occurring protein precursor underscores a biological rationale for its observed effects. The structure and origin of DNSP-11 are key to understanding its mechanism of action and its potential therapeutic applications.作者：KA Kelps·2011·被引用次数：19—Dopamine neuron stimulating peptide-11 (DNSP-11) is a synthetic, amidated 11-amino acid neuroactive peptide derived from the human GDNF pro-domain (Bradley et ...
The primary focus of research surrounding DNSP-11 is its neuroprotective activity toward dopamine neurons.Dopamine Neuron Stimulating Actions of a GDNF Propeptide Studies indicate that it can provide protection against cell death induced by agents like staurosporine and 6-hydroxydopamine (6-OHDA). This protective effect is mediated, in part, by the activation of neuroprotective signaling pathways, such as ERK1/2 phosphorylationIn vitro,DNSP-11 supports the survival of fetal mesencephalic neuronsand in vivo, DNSP-11 increases dopamine and dopamine metabolite tissue levels in the .... Furthermore, DNSP-11 has been shown to influence dopamine neuron function dynamically, suggesting it can modulate neuronal activity and potentially restore or enhance dopaminergic signaling.
Beyond its direct cellular protective effects, the methodology and effects of repeated intranasal delivery of DNSP-11 are being explored as a viable administration routeIn the MN9D dopaminergic neuronal cell line, DNSP-11provides protection against staurosporine and 6-hydroxydopamine-induced cell death, significantly .... Intranasal delivery offers a non-invasive approach to bypass the blood-brain barrier, allowing the peptide to reach the central nervous system (CNS) and exert its neuroactive properties. This method has shown promise in maintaining the peptide's efficacy in both normal and disease models, such as those mimicking Parkinson's disease.
The scientific exploration of DNSP-11 continues to expand. Studies have investigated its effects in various models, including in vivo experiments on rats where it has been delivered to the substantia nigra, a critical area for dopamine production. In these studies, DNSP-11 has been observed to increase dopamine and dopamine metabolite tissue levels.
While DNSP-11 is a compelling subject of research, it is important to note its current status as a high-quality, specialized research peptide.作者：KA Kelps·2011·被引用次数：19—Dopamine neuron stimulating peptide-11 (DNSP-11) is a synthetic, amidated 11-amino acid neuroactive peptide derived from the human GDNF pro-domain (Bradley et ... Further investigation is needed to fully elucidate its therapeutic potential and safety profile for clinical applications. However, its demonstrated neurotrophic and neuroprotective actions, coupled with promising delivery methods, position DNSP-11 as a significant area of interest for future advancements in treating neurological disorders characterized by dopamine neuron degeneration.
Join the newsletter to receive news, updates, new products and freebies in your inbox.